Search

Your search keyword '"Michael J. Eckrich"' showing total 2 results
Start Over Author "Michael J. Eckrich" Journal cancer reports
2 results on '"Michael J. Eckrich"'

1. Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation

Author

Nabila Rattani, Christina Matheny, Michael J. Eckrich, Lisa M. Madden, and Troy C. Quigg

Subjects
allogeneic hematopoietic stem cell transplantation, graft failure, parvovirus B19 infection, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. Case Two pediatric patients were diagnosed with PVB19 infection around the time of allo‐HSCT graft failure. Both cases were secondary graft failure and required second allo‐HSCT. Conclusion There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo‐HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo‐HSCT graft failure.

Published
2022
Full Text
View/download PDF

2. Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation

Author

Michael J. Eckrich, Nabila Rattani, Christina Matheny, Lisa Madden, and Troy C. Quigg

Subjects
Graft Rejection, Male, Oncology, Cancer Research, medicine.medical_specialty, Graft failure, Adolescent, Allograft failure, medicine.medical_treatment, graft failure, Secondary Graft Failure, Case Report, chemical and pharmacologic phenomena, Hematopoietic stem cell transplantation, parvovirus B19 infection, Parvoviridae Infections, Risk Factors, immune system diseases, Internal medicine, hemic and lymphatic diseases, Parvovirus B19, Human, medicine, Humans, allogeneic hematopoietic stem cell transplantation, Risk factor, RC254-282, biology, Parvovirus, business.industry, Hematopoietic Stem Cell Transplantation, Infant, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, biology.organism_classification, surgical procedures, operative, Etiology, Solid organ transplantation, business
Abstract

Background Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. Case Two pediatric patients were diagnosed with PVB19 infection around the time of allo‐HSCT graft failure. Both cases were secondary graft failure and required second allo‐HSCT. Conclusion There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo‐HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo‐HSCT graft failure.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results